https://orcid.org/0000-0002-9467-9514
References
- Boyer EW, Babu KM, Adkins JE, Mccurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103(6):1048–50. doi:10.1111/j.1360-0443.2008.02209.x.
- Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T. Kratom withdrawal: a systematic review with case series. J Psychoactive Drugs. 2019;51(1):12–8. doi:10.1080/02791072.2018.1562133.
- Singh D, Narayanan S, Müller CP, Swogger M,T, Rahim AA, Leong Bin Abdullah MFI, Vicknasingam BK. Severity of Kratom (Mitragyna speciosa Korth.) psychological withdrawal symptoms. J Psychoactive Drugs. 2018;50(5):445–50. doi:10.1080/02791072.2018.1511879.
- Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020;9(1):55–69. doi:10.1007/s40122-020-00151-x.
- Lydecker AG, Sharma A, Mccurdy CR, Avery BA, Babu KM, Boyer EW. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine. J Med Toxicol. 2016;12(4):341–9. doi:10.1007/s13181-016-0588-y.